Related references
Note: Only part of the references are listed.CD10, TDAG51, CK20, AR, INSM1, and Nestin Expression in the Differential Diagnosis of Trichoblastoma and Basal Cell Carcinoma
Cem Leblebici et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2019)
Insulinoma-associated protein 1 (INSM1) is a sensitive and highly specific marker of neuroendocrine differentiation in primary lung neoplasms: an immunohistochemical study of 345 cases, including 292 whole-tissue sections
Sanjay Mukhopadhyay et al.
MODERN PATHOLOGY (2019)
5-Iodotubercidin represses insulinoma-associated-1 expression, decreases cAMP levels, and suppresses human neuroblastoma cell growth
Chiachen Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Alleles of Insm1 determine whether RIP1-Tag2 mice produce insulinomas or nonfunctioning pancreatic neuroendocrine tumors
Shinta Kobayashi et al.
ONCOGENESIS (2019)
Insulinoma-Associated-1: From Neuroendocrine Tumor Marker to Cancer Therapeutics
Chiachen Chen et al.
MOLECULAR CANCER RESEARCH (2019)
Insulinoma-associated protein 1 expression in pancreatic neuroendocrine tumours in endoscopic ultrasound-guided fine-needle aspiration cytology: An analysis of 14 patients
Yorihiko Takase et al.
CYTOPATHOLOGY (2019)
Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites
Madhuchhanda Roy et al.
ENDOCRINE PATHOLOGY (2019)
Insulinoma-associated protein 1 immunostaining on cytology specimens: an institutional experience
Erika F. Rodriguez et al.
HUMAN PATHOLOGY (2019)
Triple marker composed of p16, CD56, and TTF1 shows higher sensitivity than INSM1 for diagnosis of pulmonary small cell carcinoma: proposal for a rational immunohistochemical algorithm for diagnosis of small cell carcinoma in small biopsy and cytology specimens
Marian Svajdler et al.
HUMAN PATHOLOGY (2019)
Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma)
Patrick S. Rush et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2018)
Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor
Masahiko Tanigawa et al.
MEDICAL MOLECULAR MORPHOLOGY (2018)
Insulinoma-Associated Protein 1 Immunostain: A Diagnostic Tool for Pulmonary Small Cell Carcinoma in Cytology
Erika F. Rodriguez et al.
ACTA CYTOLOGICA (2018)
Neuroendocrine carcinoma of the cervix: a systematic review of the literature
Clemens B. Tempfer et al.
BMC CANCER (2018)
Insulinoma-associated protein 1 is a sensitive and specific marker of neuroendocrine lung neoplasms in cytology specimens
Erika E. Doxtader et al.
CANCER CYTOPATHOLOGY (2018)
Sonic hedgehog signaling pathway promotes INSM1 transcription factor in neuroendocrine lung cancer
Chiachen Chen et al.
CELLULAR SIGNALLING (2018)
Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate
Zhixiang Xin et al.
HUMAN PATHOLOGY (2018)
INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma
Akihiko Yoshida et al.
MODERN PATHOLOGY (2018)
INSM1 Is More Sensitive and Interpretable than Conventional Immunohistochemical Stains Used to Diagnose Merkel Cell Carcinoma
Mohammed T. Lilo et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Haploinsufficiency of Insm1 Impairs Postnatal Baseline β-Cell Mass
Weihua Tao et al.
DIABETES (2018)
A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases
Shiho Kuji et al.
GYNECOLOGIC ONCOLOGY (2017)
Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas
Bryan Oronsky et al.
NEOPLASIA (2017)
INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity
Lisa M. Rooper et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)
Neuroendocrine Tumors of the Breast
Lauren Elizabeth Rosen et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Tumor-specific promoter-driven adenoviral therapy for insulinoma
Alan Wei-Shun Tseng et al.
CELLULAR ONCOLOGY (2016)
Ectopic expression of a small cell lung cancer transcription factor, INSM1 impairs alveologenesis in lung development
Chiachen Chen et al.
BMC PULMONARY MEDICINE (2016)
Breast cancer characteristics in very young Egyptian women <= 35 years
Omar Farouk et al.
BREAST CANCER-TARGETS AND THERAPY (2016)
INSM1A A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms
Jason N. Rosenbaum et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
Insulinoma-Associated Protein 1 Is a Crucial Regulator of Neuroendocrine Differentiation in Lung Cancer
Kosuke Fujino et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Insm1 controls the differentiation of pulmonary neuroendocrine cells by repressing Hes1
Shiqi Jia et al.
DEVELOPMENTAL BIOLOGY (2015)
Extra-nuclear activity of INSM1 transcription factor enhances insulin receptor signaling pathway and Nkx6.1 expression through RACK1 interaction
Tao Zhang et al.
CELLULAR SIGNALLING (2014)
Insm1 promotes endocrine cell differentiation by modulating the expression of a network of genes that includes Neurog3 and Ripply3
Anna B. Osipovich et al.
DEVELOPMENT (2014)
Small cell carcinoma of the prostate
Rosa Nadal et al.
NATURE REVIEWS UROLOGY (2014)
The prognostic significance of the circulating neuroendocrine markers chromogranin A, pro-gastrin-releasing peptide, and neuron-specific enolase in patients with small-cell lung cancer
Marina Petrovic et al.
MEDICAL ONCOLOGY (2014)
Insm1 controls development of pituitary endocrine cells and requires a SNAG domain for function and for recruitment of histone-modifying factors
Jochen E. Welcker et al.
DEVELOPMENT (2013)
Insertion of a nuclear factor kappa B DNA nuclear-targeting sequence potentiates suicide gene therapy efficacy in lung cancer cell lines
F. Cramer et al.
CANCER GENE THERAPY (2012)
Modifications to the INSM1 promoter to preserve specificity and activity for use in adenoviral gene therapy of neuroendocrine carcinomas
V. Akerstrom et al.
CANCER GENE THERAPY (2012)
Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells
Signe R. Michaelsen et al.
JOURNAL OF GENE MEDICINE (2012)
Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix
Hiroshi Kajiwara et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2009)
Beta-catenin stability, frizzled and cyclin D1 proteins expression in human breast cancer and its relation with their prognosis
B. Zengel et al.
EJC SUPPLEMENTS (2009)
Structure, expression, and biological function of INSM1 transcription factor in neuroendocrine differentiation
Michael S. Lan et al.
FASEB JOURNAL (2009)
INSM1 Promoter-Driven Adenoviral Herpes Simplex Virus Thymidine Kinase Cancer Gene Therapy for the Treatment of Primitive Neuroectodermal Tumors
Hong-Wei Wang et al.
HUMAN GENE THERAPY (2009)
Zinc Finger Transcription Factor INSM1 Interrupts Cyclin D1 and CDK4 Binding and Induces Cell Cycle Arrest
Tao Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Small cell carcinoma of the prostate - A morphologic and immunohistochemical study of 95 cases
Wenle Wang et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner
Nancy Bretschneider et al.
CANCER RESEARCH (2008)
Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympathoadrenal lineage
Hendrik Wildner et al.
DEVELOPMENT (2008)
Transient expression of the conserved zinc finger gene INSM1 in progenitors and nascent neurons throughout embryonic and adult neurogenesis
Anne Duggan et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Insulinoma-Associated 1 Has a Panneurogenic Role and Promotes the Generation and Expansion of Basal Progenitors in the Developing Mouse Neocortex
Lilla M. Farkas et al.
NEURON (2008)
An integrated approach identifies Nhlh1 and Insm1 as Sonic Hedgehog-regulated genes in developing cerebellum and medulloblastoma
Enrico De Smaele et al.
NEOPLASIA (2008)
Neurogenin 3 recruits CBP co-activator to facilitate histone H3/H4 acetylation in the target gene INSM1
Mary B. Breslin et al.
FEBS LETTERS (2007)
The Zinc-finger factor Insm1 (IA-1) is essential for the development of pancreatic β cells and intestinal endocrine cells
Mathias S. Gierl et al.
GENES & DEVELOPMENT (2006)
The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer
N Pedersen et al.
CANCER GENE THERAPY (2006)
IA1 is NGN3-dependent and essential for differentiation of the endocrine pancreas
G Mellitzer et al.
EMBO JOURNAL (2006)
Serum tumor markers in breast cancer: Are they of clinical value?
MJ Duffy
CLINICAL CHEMISTRY (2006)
NeuroD1/E47 regulates the e-box element of a novel zinc finger transcription factor, IA-1, in developing nervous system
MB Breslin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Discovery of the breast cancer gene BASE using a molecular approach to enrich for genes encoding membrane and secreted proteins
KA Egland et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The zinc-finger transcription factor INSM1 is expressed during embryo development and interacts with the cbl-associated protein
JP Xie et al.
GENOMICS (2002)
Neuroendocrine differentiation factor, IA-1, is a transcriptional repressor and contains a specific DNA-binding domain: identification of consensus IA-1 binding sequence
MB Breslin et al.
NUCLEIC ACIDS RESEARCH (2002)
Share Paper
